Return to search

SQZ Biotech grabs $65m

Watertown, Massachusetts-based SQZ Biotechnologies Company, a cell therapy company, has raised $65 million in Series D preferred stock financing.

Watertown, Massachusetts-based SQZ Biotechnologies Company, a cell therapy company, has raised $65 million in Series D preferred stock financing. Temasek led the round with participation from other backers that included GV, Illumina Ventures, Invus, JDRF T1D Fund, NanoDimension and Polaris Partners.

Source: Press Release